# OnCo record richard-carvajal (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/richard-carvajal/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "richard-carvajal" ;
  schema:name "Richard D. Carvajal"@en ;
  schema:description "Melanoma oncologist who led the tebentafusp programme in the United States and defined targeted therapy for rare melanoma subtypes."@en ;
  schema:url <https://onco.cc/people/richard-carvajal/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Carvajal%20RD%5BAuthor%5D%20uveal%20melanoma> ;
  onco:tag "uveal-melanoma", "rare-cancers" ;
  schema:jobTitle "Deputy Physician-in-Chief and Director of Medical Oncology, Northwell Health Cancer Institute" ;
  schema:sameAs <https://orcid.org/0000-0002-3796-1118> ;
  onco:cancers <https://onco.cc/cancers/uveal-melanoma/>, <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/gp100/>, <https://onco.cc/targets/kit/> ;
  onco:drugs <https://onco.cc/drugs/tebentafusp/>, <https://onco.cc/drugs/imatinib/> ;
  onco:institutions <https://onco.cc/institutions/northwell-cancer-institute/> ;
  onco:trials <https://onco.cc/trials/imcgp100-202/> ;
  schema:affiliation <https://onco.cc/institutions/northwell-cancer-institute/> .